Skip to main navigation

Main Menu

Header Nav

Our science
our pipeline
disease focus: HAE
HAE community
clinical trials
About us
Investors

Investor Menu

IR Nav

Overview
News & Events
Financials
- SEC Filings
Stock
- Stock Performance
- Analyst Coverage
Corporate Governance
Resources

Events & Presentations

Breadcrumb

Home / Investor Relations / NEWS & EVENTS / NEWS & EVENTS >> Events & Presentations

Past Events

2021 Annual General Meeting of Shareholders

Jun 29, 2021 at 1:00 PM CEST

Supporting Materials

Annual Report and auditor's report 2020 1.9 MB

Convening Notice and Agenda (incl. explanatory notes) 185.3 KB

AGM Announcement 53.6 KB

Voting Proxy 154.9 KB

12th C1-Inhibitor Deficiency Angioedema Workshop

Jun 04, 2021 at 9:45 AM CEST

Supporting Materials

PHVS 2021 C1-INH Workshop Presentation 3.7 MB

Pharvaris Presents Pharmacokinetic and Pharmacodynamic Data for Oral PHA121, Under Development for the Treatment of HAE, at 12th C1 Inhibitor Deficiency and Angioedema Workshop

Oppenheimer Rare & Orphan Disease Summit

May 21, 2021

Click for webcast

BofA Securities Virtual Health Care Conference

May 12, 2021 at 11:00 AM EDT

Click for webcast

2021 AAAAI Annual Meeting

Feb 26 - Mar 01, 2021

Supporting Materials

Pharvaris to Present Clinical Data of PHA121 for the Treatment of Hereditary Angioedema at the 2021 AAAAI Annual Meeting

Pharvaris AAAAI 2021 Late Breaker Poster L23 1.4 MB

Pharvaris Presents Pharmacodynamic Activity of Oral PHA121, Under Development for the Treatment of HAE, at the AAAAI Annual Meeting

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Presentations

Corporate Presentation

Toolkit

Print Page

Email Alerts

IR Contacts

Footer Links

Privacy Cookie notice Terms of Use

Social Links

Pharvaris 2020 - © All rights reserved